G. Diego Miralles

Immunology and Microbiology · Life Sciences

17h-index1.6kcitations24works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(14), HIV/AIDS drug development and treatment(11), HIV/AIDS Research and Interventions(9), HIV-related health complications and treatments(3), Viral-associated cancers and disorders(2)

Publications24 total

Effects of ritonavir‐boosted darunavir <i>vs</i>. ritonavir‐boosted atazanavir on lipid and glucose parameters in HIV‐negative, healthy volunteers
HIV Medicine·2009· 44 cited
Efficacy of Once-Daily Darunavir/Ritonavir 800/100 mg in HIV-Infected, Treatment-Experienced Patients With No Baseline Resistance-Associated Mutations to Darunavir
JAIDS Journal of Acquired Immune Deficiency Syndromes·2008· 38 cited
Evolution of Genotypic and Phenotypic Resistance during Chronic Treatment with the Fusion Inhibitor T-1249
AIDS Research and Human Retroviruses·2007· 27 cited
Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects
AIDS·2006· 8 cited
T‐1249 Retains Potent Antiretroviral Activity in Patients Who Had Experienced Virological Failure while on an Enfuvirtide‐Containing Treatment Regimen
The Journal of Infectious Diseases·2005· 93 cited
Short‐Term Safety and Antiretroviral Activity of T‐1249, a Second‐Generation Fusion Inhibitor of HIV
The Journal of Infectious Diseases·2004· 126 citedOpen Access
Changes in CD4+ T-Cell Differentiation Phenotype During Structured Treatment Interruption in Patients With Chronic HIV-1 Infection
JAIDS Journal of Acquired Immune Deficiency Syndromes·2003· 23 cited
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions
AIDS·2002· 56 cited
Addition of Cyclophosphamide to Antiretroviral Therapy Does Not Diminish the Cellular Reservoir in HIV-Infected Persons
AIDS Research and Human Retroviruses·2002· 17 cited
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects
Proceedings of the National Academy of Sciences·2001· 159 citedOpen Access
Host Response
2001
Evaluation of Distinct Blood Lymphocyte Populations in Human Immunodeficiency Virus Type 1–Infected Subjects in the Absence or Presence of Effective Therapy
The Journal of Infectious Diseases·1999· 26 cited
<b>Minireview</b> : Treatment of HIV Infection with Cytoreductive Agents
AIDS Research and Human Retroviruses·1998· 10 cited
Improved gastrointestinal tolerance and palatability of didanosine in adults by the use of pediatric powder formulation
Journal of the Association of Nurses in AIDS Care·1998· 4 cited
CD34+CD38−lin− Cord Blood Cells Develop into Dendritic Cells in Human Thymic Stromal Monolayers and Thymic Nodules
The Journal of Immunology·1998· 18 citedOpen Access
AIDS-related malignancies
Annals of Medicine·1998· 53 citedOpen Access
Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
The Lancet·1997· 46 cited
Neutralizing and Infection-Enhancing Antibody Responses to Human Immunodeficiency Virus Type 1 in Long-Term Nonprogressors
The Journal of Infectious Diseases·1996· 261 cited
DisseminatedNocardia farcinica infection in an AIDS patient
European Journal of Clinical Microbiology & Infectious Diseases·1994· 21 cited
Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis
Infection and Immunity·1994· 181 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

John Bartlett(5), Gabriel M. Ortiz(3), Melissa Wellons(3), Douglas F. Nixon(3), Ralph DeMasi(3), Michael Greenberg(3), Ying Zhang(3), David C. Montefiori(2), Mark Y. Stoeckle(2), David F. McDermott(2), Henry W. Murray(2), Jason Brancato(2), J Michael Kilby(2), Thomas Melby(2), Claire Raskino(2), Rebecca Spence(2), Gary Richmond(2), Becky Schweighardt(2), Clay Smith(2), Scott Lilly(2)